TP0502-B-Pharmaco-Scintigraphic-Study

Summary

This is a Phase I, open-label, single-site trial to evaluate the drug release, using scintigraphic images and mesalazine plasma levels (PK) in healthy subjects. Overall, nine \[9\] subjects will be evaluated. The subjects will receive one \[1\] radio-labelled tablet after a high fat and a rich in calories breakfast.

Timeline

Start

2013-09

Primary completion

2013-11

Completion

2013-12

Drugs

Indications